Select your country

20.12.2018
STADA’s EUR 300,000,000 1.75% Senior Notes due 2022
STADA’s EUR 300,000,000 1.75% Senior Notes due 2022

STADA and certain of its significant subsidiaries have today granted certain in rem security to secure certain capital markets indebtedness …

Read more

06.12.2018
STADA increases its stake in Pymepharco in Vietnam
STADA increases its stake in Pymepharco in Vietnam

STADA CEO Peter Goldschmidt: "An excellent basis for becoming a key leader in Vietnam"

Read more

28.11.2018
STADA: Completion of the compliance investigation
STADA: Completion of the compliance investigation

No pending or expected legal disputes in relation to former members of the Management Board or employees.

Read more

11.10.2018
STADA WINS GGB18 AWARD
STADA WINS GGB18 AWARD

STADA wins 2018 Global Generics & Biosimilars Award in “Company of the Year, EMEA” category.

Read more

03.09.2018
STADA CEO Peter Goldschmidt
STADA CEO Peter Goldschmidt

Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO

Read more